Assessment of the response to imatinib in chronic myeloid leukemia patients--comparison between the FISH, multiplex and RT-PCR methods. (Q45043877)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Assessment of the response to imatinib in chronic myeloid leukemia patients--comparison between the FISH, multiplex and RT-PCR methods (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

main subject

chronic myeloid leukemia

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

9

Gideon Rechavi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

10

Ninette Amariglio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

4

Luba Trakhtenbrot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

8

Frida Brok-Simoni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

2

Isaac Ben-Bassat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1

Pia Raanani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

7

Svetlana Itskovich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Shlomit Gan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ziva Mark

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Arnon Nagler

series ordinal

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

1 reference

1 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Haematology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

243-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

Imatinib mesylate--a new oral targeted therapy

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Chronic myelogenous leukemia: laboratory diagnosis and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Minimal residual disease in chronic myeloid leukaemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Detection and quantification of residual disease in chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

FISH for BCR-ABL on interphases of peripheral blood neutrophils but not of unselected white cells correlates with bone marrow cytogenetics in CML patients treated with imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Correlation of three methods of measuring cytogenetic response in chronic myelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Factors influencing the false positive and negative rates of BCR-ABL fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon alpha therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring the BCR-ABL gene after hematopoietic stem cell transplantation in CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00287.X

10.1111/J.1600-0609.2004.00287.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15347310%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference